An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry

Affiliations

• ¹ University of Vermont College of Medicine, Burlington, Vermont, USA.
• ² Department of Immunology, Duke University, Durham, North Carolina, USA; Marcus Center for Cellular Cures, Duke University, Durham, North Carolina, USA; Department of Pathology, Duke University, Durham, North Carolina, USA; Department of Neurosurgery, Duke University, Durham, North Carolina, USA.
• ³ Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
• ⁴ IMPACT-Center for Interventional Medicine for precision and advanced cellular therapy, Universidad de los Andes, Santiago, Chile; Cells for Cells and Consorcio Regenero, Chilean Consortium for Regenerative Medicine, Santiago, Chile.
• ⁵ Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
• ⁶ Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Ontario, Canada; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
• ⁷ Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
• ⁸ Department of Internal Medicine, Stem Cell Program and Institute for Regenerative Cures, University of California Davis, Sacramento, California, USA.
• ⁹ UF Scripps Biomedical Research, Jupiter, Florida, USA.
• ¹⁰ Laboratory of Pulmonary Investigation, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
• ¹¹ The First Affiliated Hospital, Soochow University Institutes for Translational Medicine, Suzhou, China; Institute of Health Sciences, Chinese Academy of Sciences, Shanghai, China.
• ¹² UMR U1236-MICMAC, Immunology and Cell Therapy Lab, Rennes University Hospital, Rennes, France.
• ¹³ Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, Canada; Krembil Research Institute, University Health Network, Toronto, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Canada; Department of Medicine, Division of Hematology, University of Toronto, Toronto, Canada.
• ¹⁴ Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.